These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1280952)

  • 21. Clinical and functional correlates of platelet cyclic GMP in essential hypertensives.
    Sala C; Rescaldani M; Santin E; Bolla G; Cuspidi C
    Am J Hypertens; 2009 Jun; 22(6):674-9. PubMed ID: 19325534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY; Mishra K; Chandy S; Holmes AS; Kanna R; Horowitz JD
    J Heart Valve Dis; 2006 Jan; 15(1):28-33. PubMed ID: 16480009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension.
    Gorenflo M; Bettendorf M; Brockmeier K; Ulmer HE
    Z Kardiol; 2000 Nov; 89(11):1000-8. PubMed ID: 11149265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between blood cAMP, cGMP levels and traumatic severity in the patients with acute trauma and its clinical significance.
    Bai X; Wang H; Li Z; Liu K
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):68-70. PubMed ID: 15165120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV; Manrique V
    Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI2 and NO in pregnancy.
    Magness RR; Rosenfeld CR; Hassan A; Shaul PW
    Am J Physiol; 1996 Jun; 270(6 Pt 2):H1914-23. PubMed ID: 8764239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets.
    Aburima A; Berger M; Spurgeon BEJ; Webb BA; Wraith KS; Febbraio M; Poole AW; Naseem KM
    Blood; 2021 Feb; 137(5):678-689. PubMed ID: 33538796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism.
    Massucco P; Mattiello L; Russo I; Traversa M; Doronzo G; Anfossi G; Trovati M
    Thromb Haemost; 2005 Mar; 93(3):517-26. PubMed ID: 15735804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
    Kleppe R; Jonassen I; Døskeland SO; Selheim F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet cyclic AMP in essential hypertension.
    Mazeaud MM; Le Quan Sang KH; Devynck MA
    J Hypertens; 1989 Jun; 7(6):501-6. PubMed ID: 2550542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of cAMP/cGMP in patients under a stress state.
    Chen P; Chai Y
    Chin J Traumatol; 2002 Apr; 5(2):115-7. PubMed ID: 11904075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels.
    Lieberman EH; O'Neill S; Mendelsohn ME
    Circ Res; 1991 Jun; 68(6):1722-8. PubMed ID: 1645235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in human plasma and animal tissues by solid phase extraction on silica and liquid chromatography-triple quadrupole mass spectrometry.
    Van Damme T; Zhang Y; Lynen F; Sandra P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():14-21. PubMed ID: 23153638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Variations of plasmatic cyclic nucleotides in the asthmatic patient (cyclic adenosine monophosphate and cyclic guanosine monophosphate) (author's transl)].
    Clauzel AM; Calvayrac P; Michel FB
    Poumon Coeur; 1980; 36(5):295-302. PubMed ID: 6256723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of platelet function in hypertension and diabetes.
    Hamet P; Skuherska R; Pang SC; Tremblay J
    Hypertension; 1985; 7(6 Pt 2):II135-42. PubMed ID: 3000939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C.
    MacIntyre DE; Bushfield M; Shaw AM
    FEBS Lett; 1985 Sep; 188(2):383-8. PubMed ID: 2993027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia.
    Anwaar I; Gottsäter A; Ohlsson K; Mattiasson I; Lindgärde F
    Cerebrovasc Dis; 1998; 8(6):310-7. PubMed ID: 9774747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.